background
morocco
pediatr
pneumonia
remain
seriou
public
health
problem
constitut
first
caus
mortal
due
infecti
diseas
e
etiolog
diagnosi
acut
respiratori
tract
infect
difficult
erefor
necessari
use
multiplex
realtim
polymeras
chain
reaction
assay
test
routin
set
exact
fast
identif
object
paper
present
clinic
result
pediatr
pneumonia
describ
etiolog
use
molecular
diagnosi
studi
design
tracheal
secret
collect
infant
present
respiratori
distress
isol
associ
system
sign
attend
unit
neonatolog
decemb
mai
sampl
test
multiplex
respifind
smart
fast
potenti
detect
virus
bacteria
result
infant
consid
studi
mean
age
day
suspect
acut
respiratori
tract
infect
posit
one
multipl
virus
orand
bacteria
e
major
acut
respiratori
tract
infect
viral
origin
respiratori
syncyti
virus
b
rhinoviru
coronavirus
humain
metapneumoviru
influenza
influenza
adenoviru
parainfluenza
viru
type
among
patient
mycoplasma
pneumonia
coinfect
associ
sever
respiratori
symptom
conclus
e
clinic
spectrum
respiratori
infect
complex
often
nonspecif
us
earli
fast
detect
relat
caus
agent
crucial
e
use
multiplex
real
time
polymeras
chain
reaction
may
help
choos
accur
treatment
reduc
overal
use
unnecessari
antibiot
preserv
intestin
flora
decreas
nosocomi
infect
reduc
length
hospit
accord
world
health
organ
pneumonia
defin
acut
respiratori
tract
infect
rti
affect
lung
tissu
bronchi
bronchiol
alveolar
tissu
morocco
pediatr
pneumonia
remain
seriou
public
health
problem
constitut
first
caus
mortal
due
infecti
diseas
pneumonia
major
caus
childhood
morbid
mortal
worldwid
e
estim
million
children
die
annual
year
age
greatest
risk
death
neonat
period
e
epidemiolog
etiolog
pneumonia
vari
countri
countri
region
region
develop
countri
incid
pneumonia
among
children
year
age
episod
per
childyear
compar
episod
per
childyear
develop
countri
pneumonia
caus
varieti
microorgan
virus
bacteria
fungi
virus
common
caus
agent
children
year
age
especi
respiratori
syncyti
viru
rsv
rhinoviru
rv
influenza
iv
parainfluenza
virus
piv
adenoviru
adv
least
virus
associ
pneumonia
eir
distribut
vari
season
geograph
region
age
group
consid
frequenc
viral
infect
antibacteri
therapi
often
employ
inadequ
unnecessarili
e
etiolog
diagnosi
pneumonia
difficult
due
similar
clinic
present
also
due
overlap
symptom
virus
bacteria
differ
virus
reason
use
multiplex
realtim
polymeras
chain
reaction
pcr
assay
test
routin
set
exact
fast
identif
appear
necessari
ey
detect
wide
rang
viral
bacteri
pathogen
simultan
singl
reaction
higher
sensit
specif
hour
e
aim
studi
present
clinic
result
pediatr
pneumonia
describ
epidemiolog
etiolog
among
infant
live
morocco
admit
neonatolog
unit
prospect
studi
conduct
decemb
may
nation
refer
center
neonatolog
nutrit
medic
research
laboratori
children
hospit
rabat
includ
studi
infant
admit
respiratori
distress
isol
associ
system
sign
infant
regardless
gestat
age
geograph
origin
whose
actual
age
less
month
hospit
suspicion
pneumonia
inclus
criteria
base
diagnosi
clinic
symptom
respiratori
symptom
e
infant
recruit
present
symptom
associ
definit
clinic
pneumonia
ey
defin
histori
cough
rais
respiratori
rate
chest
wall
indraw
newborn
age
day
infant
transient
respiratori
distress
respiratori
distress
cardiac
neurolog
malform
origin
exclud
studi
data
enter
sheet
contain
epidemiolog
clinic
paraclin
data
clinic
evalu
patient
well
inform
regard
patient
famili
member
e
studi
data
follow
epidemiolog
data
age
sex
socioeconom
statu
ii
environ
patient
home
condit
health
histori
iii
clinic
data
symptom
evolut
iv
paraclin
data
biolog
analysi
complet
blood
count
creactiv
protein
crp
rtpcr
chest
xray
interpret
pediatrician
sampl
e
tracheal
secret
ts
sampl
collect
first
hour
hospit
transfer
neonatolog
depart
medic
research
laboratori
children
hospit
rabat
e
collect
ts
perform
accord
standard
procedur
use
tracheal
aspir
probe
introduc
resist
encount
retract
approxim
cm
follow
releas
vacuum
probe
delic
remov
use
turn
movement
secret
aspir
steril
collector
tube
e
sampl
analyz
accord
manufactur
instruct
use
respifind
smart
fast
assay
detect
differenti
simultan
respiratori
pathogen
virus
influenza
virus
b
influenza
viru
respiratori
syncyti
virus
rsv
b
parainfluenza
virus
rhinoviru
rv
enteroviru
coronavirus
cor
human
metapneumoviru
hmpv
adenoviru
adv
bocaviru
bov
bacteria
legionella
pneumophila
bordetella
pertussi
mycoplasma
pneumonia
chlamydophila
pneumonia
ts
sampl
elut
elut
buffer
e
assay
compris
preamplif
step
combin
revers
transcriptas
multiplex
target
amplif
pcr
follow
probe
hybrid
step
probe
ligat
step
probe
amplif
step
e
intern
amplif
control
iac
ad
begin
procedur
differenti
sampl
trueneg
result
sampl
falseneg
result
due
pcr
failur
target
detect
use
capillari
electrophoresi
statist
analysi
perform
packag
social
scienc
analyz
use
softwar
pearson
p
valu
consid
statist
signific
e
parent
particip
given
inform
written
consent
e
protocol
studi
approv
ethic
committe
biomed
research
faculti
medicin
pharmaci
rabat
morocco
e
subject
studi
total
infant
ey
present
respiratori
symptom
suspicion
pneumonia
among
male
femal
sex
ratio
e
mean
age
day
patient
middl
socioeconom
statu
low
socioeconom
statu
one
high
socioeconom
statu
accord
parent
famili
pet
home
damp
home
live
smoker
tabl
patient
includ
studi
consciou
least
one
respiratori
symptom
high
frequenc
dyspnea
repres
case
cough
rhinorrhea
fever
frequent
respect
tabl
patient
perform
chest
xray
abnorm
case
abnorm
chest
xray
result
show
confirm
infect
p
use
rtpcr
techniqu
tabl
mean
durat
hospit
day
length
stay
dead
infant
includ
day
period
death
complic
nosocomi
infect
detect
e
result
multiplex
rtpcr
show
presenc
type
virus
one
speci
bacteria
least
one
pathogen
detect
sampl
e
preval
viru
rsv
detect
sampl
type
b
repres
respect
total
sampl
iv
repres
whose
one
patient
subtyp
iv
rv
detect
sampl
adv
detect
sampl
sampl
hmpv
detect
sampl
detect
sampl
patient
mycoplasma
pneumonia
coinfect
seen
specimen
repres
sampl
posit
sampl
case
coinfect
two
virus
sampl
posit
coinfect
virusbacteria
detect
case
e
frequent
detect
coinfect
combin
rsvrhino
n
n
tabl
accord
studi
season
distribut
virus
vari
graphic
show
viral
infect
essenti
present
coldest
season
autumn
winter
season
respiratori
virus
well
establish
rsv
b
preval
virus
appear
frequent
septemb
decemb
e
case
iv
detect
januari
februari
juli
influenza
detect
februari
predomin
may
rv
detect
studi
without
pick
e
virus
hmpv
adv
less
frequent
figur
compar
epidemiolog
clinic
radiolog
characterist
posit
neg
sampl
e
proport
posit
male
p
e
rate
prematur
present
posit
case
p
rest
gener
characterist
includ
age
socioeconom
statu
environ
patient
comparison
two
group
show
signific
tabl
clinic
sign
symptom
present
group
higher
frequenc
posit
group
e
differ
statist
signific
nasal
flare
present
posit
case
p
tabl
e
human
respiratori
tract
expos
viral
bacteri
infect
pneumonia
major
clinic
present
lower
acut
respiratori
tract
infect
consid
major
caus
hospit
among
children
worldwid
e
mortal
morbid
rate
higher
especi
first
year
life
sever
laboratori
techniqu
use
detect
agent
respons
rti
includ
immunofluoresc
enzym
immunoassay
isol
cultur
molecular
biolog
e
current
molecular
method
detect
larg
panel
virus
bacteria
also
make
etiolog
diagnosi
effici
contrast
tradit
method
less
sensit
suitabl
rapid
diagnosi
children
hospit
rabat
chr
rti
frequent
especi
acut
lower
rti
repres
larg
proport
allcaus
consult
erefor
precis
diagnosi
necessari
current
larg
varieti
molecular
assay
develop
commerci
ruuskanen
et
al
report
evid
viral
infect
present
pediatr
case
use
molecular
diagnost
studi
first
time
prospect
data
regard
etiolog
acut
respiratori
tract
infect
servic
neonatolog
chr
evalu
perform
respifind
smart
fast
moroccan
infant
clinic
suspect
pneumonia
high
percentag
sampl
posit
e
major
patient
viral
infect
addit
virus
test
panel
detect
rsv
rv
cor
hmpv
iva
iv
adv
dabischruth
et
al
report
higher
clinic
sensit
detect
viru
ey
found
respiratori
virus
tracheal
secret
ts
sampl
high
posit
similar
studi
molecular
method
perform
studi
preval
pathogen
rsv
ab
detect
sampl
accord
sever
studi
rsv
b
known
common
caus
pneumonia
infant
young
children
worldwid
hall
cb
et
al
suggest
rsv
greatest
diseas
burden
hospit
children
outpati
especi
children
year
age
higher
proport
infant
due
matern
antibodi
ineffect
prevent
rsv
infect
systemat
review
realiz
shi
et
al
estim
million
episod
acut
lower
respiratori
infect
caus
rsv
third
first
year
life
among
children
age
less
year
lowincom
middleincom
countri
ey
also
estim
million
episod
highincom
countri
e
second
viru
detect
studi
rv
e
human
rv
frequent
caus
agent
upper
lower
respiratori
tract
infect
main
caus
agent
common
cold
caus
sever
ari
infant
young
children
advanc
virolog
adv
detect
case
one
major
caus
lower
respiratori
tract
infect
children
age
year
adult
rare
newborn
infant
children
age
year
children
age
less
two
year
low
rate
e
iv
known
season
outbreak
ari
week
winter
accord
studi
realiz
brazil
canela
et
al
among
children
age
year
viru
posit
higher
frequenc
iv
piv
subtyp
detect
case
report
much
less
frequent
caus
ari
e
group
coronaviru
heterogen
hcov
studi
detect
e
clinic
symptom
coronaviru
newli
discov
virus
involv
rti
human
bocaviru
hmpv
similar
respiratori
virus
recogn
frequent
young
age
result
similar
studi
conduct
among
children
infant
etiolog
result
coincid
studi
realiz
toulouz
univers
hospit
among
children
suffer
ari
sampl
analyz
use
respifind
assay
preval
viru
rsv
frequent
detect
regard
bacteria
patient
mycoplasma
pneumonia
case
treat
antibiot
e
low
preval
bacteria
may
explain
use
antibiot
urgent
act
use
case
suspect
art
beckmann
hirsch
detect
mycoplasma
pneumonia
among
pediatr
adult
patient
accord
sever
studi
incid
coinfect
depend
differ
popul
test
panel
bruijnesteijn
van
coppenraet
et
al
report
molecular
assay
reveal
high
frequenc
doubl
infect
specif
coronavirus
rsv
rv
frequent
detect
mix
infect
e
current
studi
show
coinfect
posit
sampl
high
frequenc
combin
rsvrhino
sever
studi
point
clinic
sever
associ
coinfect
one
viru
anoth
studi
report
coinfect
associ
increas
clinic
sever
result
show
signific
differ
clinic
sever
coinfect
singl
infect
also
clinic
present
differ
caus
agent
often
similar
e
associ
viral
detect
clinic
characterist
show
predomin
respiratori
sign
special
dyspnea
polypnea
cyanosi
labor
breath
wheez
rhonch
clinic
symptom
sign
concur
studi
realiz
singh
et
al
among
infant
age
less
month
e
clinic
spectrum
respiratori
infect
complex
often
nonspecif
erefor
earli
rapid
detect
relat
caus
agent
crucial
multiplex
rtpcr
assay
respiratori
infect
use
routin
diagnosi
morocco
eir
use
near
futur
may
help
pediatrician
choos
appropri
treatment
reduc
overal
use
unnecessari
antibiot
stop
use
patient
infect
viru
initi
antivir
therapi
preserv
intestin
flora
help
decreas
nosocomi
infect
reduc
length
hospit
would
also
decreas
manag
cost
multiplex
rtpcr
assay
respiratori
infect
like
subject
futur
studi
larger
sampl
differ
age
group
e
data
use
support
find
studi
includ
within
articl
